Dashenlin Pharm Grp Co Ltd (603233) — Strategic Asset Allocation Index
Dashenlin Pharm Grp Co Ltd (603233) has a Strategic Asset Allocation Index of 81.8% as of June 2023. Strategic assets (PP&E of CN¥6.25 Billion plus long-term investments of CN¥-) total CN¥6.25 Billion, measured against net assets of CN¥7.64 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See 603233 net asset quality score to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Dashenlin Pharm Grp Co Ltd Strategic Asset Allocation Index (2012–2022)
This chart shows how Dashenlin Pharm Grp Co Ltd's Strategic Asset Allocation Index has evolved across 11 annual periods from 2012 to 2022. As of June 2023, the index stands at 81.8%, representing strategic assets of CN¥6.25 Billion against net assets of CN¥7.64 Billion CNY. For live market cap and overall valuation, see 603233 stock market capitalisation.
Annual Strategic Asset Allocation Index for Dashenlin Pharm Grp Co Ltd (2012–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Dashenlin Pharm Grp Co Ltd from 2012 to 2022, covering 11 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See what is Dashenlin Pharm Grp Co Ltd's book value for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 88.8% | CN¥6.09 Billion | CN¥6.09 Billion | CN¥- | CN¥6.86 Billion | ▼ -6.5 pp |
| 2021 | 95.2% | CN¥5.65 Billion | CN¥5.65 Billion | CN¥- | CN¥5.94 Billion | ▲ +72.1 pp |
| 2020 | 23.1% | CN¥1.29 Billion | CN¥1.29 Billion | CN¥- | CN¥5.57 Billion | ▼ -2.7 pp |
| 2019 | 25.8% | CN¥1.12 Billion | CN¥1.12 Billion | CN¥- | CN¥4.33 Billion | ▼ -6.0 pp |
| 2018 | 31.9% | CN¥983.18 Million | CN¥983.18 Million | CN¥- | CN¥3.09 Billion | ▲ +3.3 pp |
| 2017 | 28.6% | CN¥801.55 Million | CN¥801.55 Million | CN¥- | CN¥2.80 Billion | ▼ -18.0 pp |
| 2016 | 46.6% | CN¥625.16 Million | CN¥625.16 Million | CN¥- | CN¥1.34 Billion | ▼ -7.4 pp |
| 2015 | 54.0% | CN¥551.58 Million | CN¥551.58 Million | CN¥- | CN¥1.02 Billion | ▼ -22.8 pp |
| 2014 | 76.8% | CN¥441.66 Million | CN¥441.66 Million | CN¥- | CN¥574.85 Million | ▲ +16.6 pp |
| 2013 | 60.2% | CN¥355.04 Million | CN¥355.04 Million | CN¥- | CN¥589.93 Million | ▲ +41.7 pp |
| 2012 | 18.5% | CN¥70.56 Million | CN¥70.56 Million | CN¥- | CN¥381.11 Million | — |